OP-1206alpha-CD Phase II Study

A multiple-center, randomized, double-blind, placebo-controlled, parallel-group comparison study in idiopathic carpal tunnel syndrome

Status

Unknown

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080221461

Enrollment

177

Registered

2011-05-18

Start date

2011-05-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic carpal tunnel syndrome

Interventions

investigational material(s) Generic name etc : OP-1206alpha-CD INN of investigational material : limaprost Therapeutic category code : 219 Other cardiovascular agents Dosage and Administration for Inv

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. 20 years or older of age 2. Outpatient 3. Idiopathic carpal tunnel syndrome patients

Exclusion criteria

Exclusion criteria: Patients who needs carpal tunnel syndrome surgery

Design outcomes

Primary

Measure	Time frame
Efficacy and safety.	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026